• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global hospital infection therapeutics market grew at a CAGR of around 5% during 2014-2019. Hospital infection therapeutics refers to various pharmaceutical drugs used for the treatment of nosocomial infections. These infections can be acquired at hospitals, nursing homes, rehabilitation facilities and other clinical settings and are usually treated by antiviral, antibacterial and antifungal medicines. The antibacterial therapeutics consist of cell wall synthesis and protein synthesis inhibitors, such as vancomycin, carbapenems, cephalosporins, linezolid, aminoglycosides and tigecycline. The antifungal therapeutics include caspofungin and Amphotericin B. These drugs aid in preventing the instances of hospital-acquired pneumonia, urinary tract infections (UTIs), gastrointestinal disorders, bloodstream infections and surgical site infections.

The increasing prevalence of hospital-acquired diseases (HAD) is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Resulting from the deterioration of hygiene facilities in hospitals and other healthcare institutions, there has been a significant increase in the occurrence of hospital-acquired pneumonia and other infections, which is contributing to the increasing demand for hospital infection therapeutics. Additionally, various product innovations, such as the development of advanced microbial wound care drugs, coverings and vaccines, are acting as other growth-inducing factors. Product manufacturers are developing antimicrobial drugs and pipeline drug molecules that are effective against multi-drug resistant infections and can be used for the treatment of infections with specific symptoms. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are expected to drive the market further. Looking forward, IMARC Group expects the global hospital infection therapeutics market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hospital infection therapeutics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, drug type and indication.

Breakup by Drug Type:

  • Anti-bacterial Drugs
  • Anti-fungal Drugs
  • Anti-viral Drugs
  • Others
     

Breakup by Indication:

  • Blood Stream Infections
  • Urinary Tract Infections
  • Surgical Site Infections
  • Pneumonia
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc (AbbVie Inc.), AstraZeneca Plc, Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), Gilead Sciences Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc, Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global hospital infection therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hospital infection therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hospital infection therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Hospital Infection Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Type
    6.1    Anti-bacterial Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Anti-fungal Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Anti-viral Drugs
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Indication
    7.1    Blood Stream Infections    
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Urinary Tract Infections
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Surgical Site Infections
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pneumonia
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Allergan Plc (AbbVie Inc.)
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials 
           13.3.1.4 SWOT Analysis
        13.3.2    AstraZeneca Plc
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bayer Aktiengesellschaft
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bristol-Myers Squibb Company
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    F. Hoffmann-La Roche AG (Roche Holding AG)
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio 
           13.3.5.3 SWOT Analysis
        13.3.6    Gilead Sciences Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
           13.3.6.3 Financials 
           13.3.6.4 SWOT Analysis
        13.3.7    GlaxoSmithKline Plc
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials 
           13.3.7.4 SWOT Analysis
        13.3.8    Johnson & Johnson
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials 
           13.3.8.4 SWOT Analysis
        13.3.9    Merck & Co. Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials 
           13.3.9.4 SWOT Analysis
        13.3.10    Pfizer Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio 
           13.3.10.3 Financials 
           13.3.10.4 SWOT Analysis
        13.3.11    Sanofi S.A.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio 
           13.3.11.3 Financials 
           13.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Hospital Infection Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Hospital Infection Therapeutics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Hospital Infection Therapeutics Market: Breakup by Drug Type (in %), 2019
Figure 4: Global: Hospital Infection Therapeutics Market: Breakup by Indication (in %), 2019
Figure 5: Global: Hospital Infection Therapeutics Market: Breakup by Region (in %), 2019
Figure 6: Global: Hospital Infection Therapeutics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 7: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 8: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 9: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Hospital Infection Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Hospital Infection Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Hospital Infection Therapeutics (Pneumonia) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Hospital Infection Therapeutics (Pneumonia) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Hospital Infection Therapeutics (Other Indications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Hospital Infection Therapeutics (Other Indications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: North America: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: North America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: United States: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: United States: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Canada: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Canada: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Asia Pacific: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Asia Pacific: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: China: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: China: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Japan: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Japan: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: India: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: India: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: South Korea: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: South Korea: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Australia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Australia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: Indonesia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: Indonesia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Europe: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Europe: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Germany: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Germany: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: France: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: France: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: United Kingdom: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: United Kingdom: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Italy: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Italy: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Spain: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Spain: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Russia: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Russia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Latin America: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Latin America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Brazil: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Brazil: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Mexico: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Mexico: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Others: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Middle East and Africa: Hospital Infection Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Middle East and Africa: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Global: Hospital Infection Therapeutics Industry: SWOT Analysis
Figure 74: Global: Hospital Infection Therapeutics Industry: Value Chain Analysis
Figure 75: Global: Hospital Infection Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Hospital Infection Therapeutics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2020-2025
Table 3: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Indication (in Million US$), 2020-2025
Table 4: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 5: Global: Hospital Infection Therapeutics Market Structure
Table 6: Global: Hospital Infection Therapeutics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links